243 related articles for article (PubMed ID: 35687817)
41. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.
Matolcsy A; Casali P; Warnke RA; Knowles DM
Blood; 1996 Nov; 88(10):3937-44. PubMed ID: 8916960
[TBL] [Abstract][Full Text] [Related]
42. Tee-ing up a New Follicular Lymphoma Classification System.
Melnick AM
Blood Cancer Discov; 2022 Sep; 3(5):374-377. PubMed ID: 35917283
[TBL] [Abstract][Full Text] [Related]
43. Activating STAT6 mutations in follicular lymphoma.
Yildiz M; Li H; Bernard D; Amin NA; Ouillette P; Jones S; Saiya-Cork K; Parkin B; Jacobi K; Shedden K; Wang S; Chang AE; Kaminski MS; Malek SN
Blood; 2015 Jan; 125(4):668-79. PubMed ID: 25428220
[TBL] [Abstract][Full Text] [Related]
44. PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.
Szumera-Ciećkiewicz A; Poleszczuk J; Kuczkiewicz-Siemion O; Paszkiewicz-Kozik E; Rymkiewicz G; Sokół K; Borysiuk A; Kotarska M; Kawecka M; Owczarek D; Pytlak B; Walewski J; Prochorec-Sobieszek M
Pathol Res Pract; 2020 Oct; 216(10):153096. PubMed ID: 32853965
[TBL] [Abstract][Full Text] [Related]
45. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.
Rawal S; Chu F; Zhang M; Park HJ; Nattamai D; Kannan S; Sharma R; Delgado D; Chou T; Lin HY; Baladandayuthapani V; Luong A; Vega F; Fowler N; Dong C; Davis RE; Neelapu SS
J Immunol; 2013 Jun; 190(12):6681-93. PubMed ID: 23686488
[TBL] [Abstract][Full Text] [Related]
46. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
Pangault C; Amé-Thomas P; Ruminy P; Rossille D; Caron G; Baia M; De Vos J; Roussel M; Monvoisin C; Lamy T; Tilly H; Gaulard P; Tarte K; Fest T
Leukemia; 2010 Dec; 24(12):2080-9. PubMed ID: 20944673
[TBL] [Abstract][Full Text] [Related]
47. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
[TBL] [Abstract][Full Text] [Related]
48. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
Araujo-Ayala F; Pérez-Galán P; Campo E
Hematol Oncol; 2021 Jun; 39 Suppl 1():83-87. PubMed ID: 34105816
[TBL] [Abstract][Full Text] [Related]
49. Highly clonal regulatory T-cell population in follicular lymphoma - inverse correlation with the diversity of CD8
Liu X; Venkataraman G; Lin J; Kiyotani K; Smith S; Montoya M; Nakamura Y; Kline J
Oncoimmunology; 2015 May; 4(5):e1002728. PubMed ID: 26155390
[TBL] [Abstract][Full Text] [Related]
50. m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
Zhang T; Liu H; Gao F; Gong W; Cui Y; He J; Li L; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Zhang H; Wang X
Front Immunol; 2022; 13():922471. PubMed ID: 35734168
[TBL] [Abstract][Full Text] [Related]
51. Follicular lymphoma: The long and winding road leading to your cure?
Gordon MJ; Smith MR; Nastoupil LJ
Blood Rev; 2023 Jan; 57():100992. PubMed ID: 35908982
[TBL] [Abstract][Full Text] [Related]
52. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
[TBL] [Abstract][Full Text] [Related]
53. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
54. Establishment and characterization of a novel 'double-hit' follicular lymphoma cell line, FL-SJC.
Chen M; Jiang G; Liu Y; Li D; Li T; Peng J; Jiang Q; You H; Ba R; Pan J; Li M; Long W; Yan J; Zhu Y; Wang Y; Xi X; Mao J; Shi X
J Cell Mol Med; 2020 Jul; 24(14):7928-7938. PubMed ID: 32459397
[TBL] [Abstract][Full Text] [Related]
55. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
Glas AM; Knoops L; Delahaye L; Kersten MJ; Kibbelaar RE; Wessels LA; van Laar R; van Krieken JH; Baars JW; Raemaekers J; Kluin PM; van't Veer LJ; de Jong D
J Clin Oncol; 2007 Feb; 25(4):390-8. PubMed ID: 17200149
[TBL] [Abstract][Full Text] [Related]
56. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
57. PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival.
Yang ZZ; Grote DM; Ziesmer SC; Xiu B; Novak AJ; Ansell SM
Blood Cancer J; 2015 Feb; 5(2):e281. PubMed ID: 25700246
[TBL] [Abstract][Full Text] [Related]
58. T-cell phenotype including CD57
Yang ZZ; Kim HJ; Wu H; Tang X; Yu Y; Krull J; Larson DP; Moore RM; Maurer MJ; Pavelko KD; Jalali S; Pritchett JC; Mudappathi R; Wang J; Villasboas JC; Mondello P; Novak AJ; Ansell SM
Blood Cancer J; 2023 Aug; 13(1):124. PubMed ID: 37591873
[TBL] [Abstract][Full Text] [Related]
59. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
Jardin F; Gaulard P; Buchonnet G; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Picquenot JM; Duval C; Parmentier F; Tilly H; Bastard C
Leukemia; 2002 Nov; 16(11):2309-17. PubMed ID: 12399977
[TBL] [Abstract][Full Text] [Related]
60. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]